실시간 바카라사이트 supplies ROK Army Logistics Command with 63,300 six-type narcotic screening kits

- "Expanding role in national defense drug response system following support to Military Manpower Administration" - "Strengthening military health and safety with 실시간 바카라사이트’s rapid and accurate multiplex diagnostic technology"

2025-06-23     Lee, Young Sung
실시간 바카라사이트 6-type narcotic drug diagnostic kit. (Source: 실시간 바카라사이트)

[by Lee, Young Sung] 실시간 바카라사이트, a company specializing in diagnostic kits, announced on June 23 that it will supply a total of 63,300 simultaneous drug diagnostic kits to the ROK Army Logistics Command.

The product to be supplied is a diagnostic k실시간 바카라사이트 capable of rapidly and simultaneously detecting six types of drugs in human urine: methamphetamine (MET), cannabis (THC), cocaine (COC), morphine (OPI), ketamine (KET), and ecstasy (MDMA). The k실시간 바카라사이트 is reported to offer enhanced accuracy in add실시간 바카라사이트ion to improved user convenience.

실시간 바카라사이트 is currently in the process of sequentially supplying 150,000 units of the same diagnostic kit to the Military Manpower Administration. With the recent contract to supply the Army Logistics Command, the company has expanded its distribution scope further into the national defense sector.

실시간 바카라사이트's simultaneous drug diagnostic kit delivers results within 10 minutes and is designed for user-friendly operation, making it accessible for use by anyone without specialized training.

In add실시간 바카라사이트ion, the k실시간 바카라사이트 is optimized for point-of-care diagnostics due to 실시간 바카라사이트s compact design, enabling reliable testing w실시간 바카라사이트hout the need for specialized equipment or add실시간 바카라사이트ional procedures.

The recent delivery to the Army Logistics Command has raised expectations for potential expansion of the product’s use in the entire military system.

“The adoption of GenBody products in the defense sector, following their use by the Military Manpower Administration, serves as a testament to our technological prowess and reliability,” said Jeong Jeom-gyu, CEO of GenBody. “We will continue to advance our technology and strengthen product competitiveness to fulfill our social responsibility in preventing the spread of drugs and enabling early intervention.”

According to GenBody, its simultaneous drug diagnostic technology is garnering significant attention not only in the Korean market but also internationally. The company’s drug detection solution is currently under consideration for adoption by public institutions, law enforcement agencies, and airport security authorities in major countries across Asia and Latin America.

On the other hand, 실시간 바카라사이트 has officially initiated its listing process by submitting a preliminary listing review application to the Korea Exchange in March. Korea Investment & Securities is serving as the lead underwriter for the offering.